| 87 | Humans |
| 51 | Animals |
| 33 | Coronavirus |
| 29 | Human |
| 25 | Severe acute respiratory syndrome |
| 20 | SARS Virus (genetics) |
| 18 | Severe Acute Respiratory Syndrome (virology) |
| 17 | Severe Acute Respiratory Syndrome (epidemiology) |
| 17 | Molecular Sequence Data |
| 16 | Amino Acid Sequence |
| 15 | SARS Virus (metabolism) |
| 14 | Disease Outbreaks |
| 13 | Male |
| 12 | Viral Nonstructural Proteins (metabolism) |
| 12 | Spike Glycoprotein, Coronavirus |
| 12 | SARS Virus (pathogenicity) |
| 11 | Severe Acute Respiratory Syndrome (transmission) |
| 11 | Female |
| 11 | Coronavirus (genetics) |
| 11 | COVID-19 |
| 10 | Virus Replication |
| 10 | Viral disease |
| 10 | Viral Nonstructural Proteins (genetics) |
| 10 | Phylogeny |
| 10 | Microbiology |
| 10 | Emerging disease |
| 10 | Coronavirus Infections (virology) |
| 10 | Coronavirus Infections (epidemiology) |
| 10 | Adult |
| 9 | Virus |
| 9 | SARS-CoV-2 |
| 9 | SARS Virus |
| 9 | Public health |
| 9 | Influenza, Human (epidemiology) |
| 9 | China (epidemiology) |
| 9 | Betacoronavirus |
| 9 | Antiviral |
| 8 | Viral Nonstructural Proteins (chemistry) |
| 8 | SARS Virus (immunology) |
| 8 | SARS Virus (chemistry) |
| 8 | Pneumonia |
| 8 | Models, Molecular |
| 8 | Middle Aged |
| 8 | France |
| 8 | Epidemiology |
| 8 | Coronavirus Infections (transmission) |
| 8 | Communicable Diseases, Emerging (epidemiology) |
| 8 | Cell Line |
| 7 | Zoonosis |
| 7 | Virus Diseases (epidemiology) |
| 7 | Virology |
| 7 | Viral Proteins (metabolism) |
| 7 | Viral Envelope Proteins (metabolism) |
| 7 | Viral Envelope Proteins (chemistry) |
| 7 | Severe Acute Respiratory Syndrome (immunology) |
| 7 | Severe Acute Respiratory Syndrome (diagnosis) |
| 7 | SARS Virus (physiology) |
| 7 | SARS Virus (isolation & purification) |
| 7 | Review |
| 7 | RNA, Viral (genetics) |
| 7 | Protein Binding |
| 7 | Membrane Glycoproteins (metabolism) |
| 7 | Infection |
| 7 | Genome, Viral |
| 7 | Coronavirus Infections (diagnosis) |
| 7 | Chiroptera (virology) |
| 7 | Child |
| 7 | Base Sequence |
| 7 | Antiviral Agents (pharmacology) |
| 6 | Virus Diseases (transmission) |
| 6 | Viral Proteins (genetics) |
| 6 | Vero Cells |
| 6 | Severe Acute Respiratory Syndrome (prevention & control) |
| 6 | RNA Replicase (genetics) |
| 6 | RNA Replicase (chemistry) |
| 6 | Pneumonia, Viral (epidemiology) |
| 6 | Models, Biological |
| 6 | Mice |
| 6 | Methyltransferases (metabolism) |
| 6 | Membrane Glycoproteins (chemistry) |
| 6 | Influenza |
| 6 | Global Health |
| 6 | Exoribonucleases (metabolism) |
| 6 | Epidemic |
| 6 | Coronavirus Infections (veterinary) |
| 6 | Coronavirus (classification) |
| 6 | Communicable Diseases, Emerging (virology) |
| 6 | Chlorocebus aethiops |
| 6 | Antibodies, Viral (immunology) |
| 5 | coronavirus |
| 5 | Young Adult |
| 5 | Travel |
| 5 | Swine |
| 5 | Sequence Homology, Amino Acid |
| 5 | SARS Virus (enzymology) |
| 5 | Risk Factors |
| 5 | RNA, Viral (metabolism) |
| 5 | RNA Replicase (metabolism) |
| 5 | Protein |
| 5 | Protein Conformation |
| 5 | Pandemics |
| 5 | Influenza, Human (transmission) |
| 5 | Exoribonucleases (genetics) |
| 5 | Crystallography, X-Ray |
| 5 | Communicable Diseases, Emerging (prevention & control) |
| 5 | Child, Preschool |
| 5 | Adolescent |
| 4 | Zoonoses (epidemiology) |
| 4 | Viruses (classification) |
| 4 | Virus Internalization |
| 4 | Virus Diseases (prevention & control) |
| 4 | Viral Vaccines (immunology) |
| 4 | Viral Envelope Proteins (genetics) |
| 4 | Veterinary |
| 4 | Treatment |
| 4 | Surveillance |
| 4 | Severe acute respiratory syndrome virus |
| 4 | Risk factor |
| 4 | Respiratory tract |
| 4 | Respiratory disease |
| 4 | Receptors, Virus (metabolism) |
| 4 | Real-Time Polymerase Chain Reaction |
| 4 | RNA, Viral (biosynthesis) |
| 4 | Protein Structure, Tertiary |
| 4 | Polymerase Chain Reaction |
| 4 | Nosocomial infection |
| 4 | Neutralization Tests |
| 4 | Mutation (genetics) |
| 4 | Methyltransferases (genetics) |
| 4 | Medicine |
| 4 | Hong Kong (epidemiology) |
| 4 | Hemorrhagic fever |
| 4 | Genetic Variation |
| 4 | Evolution |
| 4 | Crystallization |
| 4 | Coronavirus Infections |
| 4 | Coronavirus Infections (prevention & control) |
| 4 | Coronavirus (isolation & purification) |
| 4 | Communicable Diseases, Emerging (transmission) |
| 4 | Cloning, Molecular |
| 4 | Chiroptera |
| 4 | Betacoronavirus (isolation & purification) |
| 4 | Avian influenza |
| 4 | Aged |
| 3 | Zoonoses (virology) |
| 3 | World |
| 3 | World Health Organization |
| 3 | West Nile virus |
| 3 | Viruses (isolation & purification) |
| 3 | Virulence |
| 3 | Viral Proteins (chemistry) |
| 3 | Viral Nonstructural Proteins (isolation & purification) |
| 3 | Viral Envelope Proteins (immunology) |
| 3 | Transmission |
| 3 | Transmissible gastroenteritis virus (genetics) |
| 3 | Transfusion |
| 3 | Transfection |
| 3 | Structure-Activity Relationship |
| 3 | Structure activity relation |
| 3 | Severe Acute Respiratory Syndrome (therapy) |
| 3 | SARS Virus (growth & development) |
| 3 | SARS Virus (drug effects) |
| 3 | SARS Virus (classification) |
| 3 | SAR |
| 3 | Reverse Transcriptase Polymerase Chain Reaction |
| 3 | Respiratory system |
| 3 | Recombinant Proteins (metabolism) |
| 3 | Recombinant Proteins (isolation & purification) |
| 3 | Recombinant Proteins (biosynthesis) |
| 3 | RNA, Viral (chemistry) |
| 3 | RNA Replicase (isolation & purification) |
| 3 | RNA Replicase (antagonists & inhibitors) |
| 3 | Public Health |
| 3 | Prevention |
| 3 | Population Surveillance |
| 3 | Pneumonia, Viral (transmission) |
| 3 | Pneumonia, Viral (diagnosis) |
| 3 | Plasmodium falciparum |
| 3 | Pathogenic |
| 3 | Pandemics (prevention & control) |
| 3 | Mutation |
| 3 | Models, Statistical |
| 3 | Mice, Inbred BALB C |
| 3 | Methyltransferases (chemistry) |
| 3 | Membrane Glycoproteins (immunology) |
| 3 | Membrane Fusion (physiology) |
| 3 | Influenza, Human (virology) |
| 3 | Infant |
| 3 | In vitro |
| 3 | Host-Pathogen Interactions |
| 3 | Hemorrhagic Fever, Ebola (epidemiology) |
| 3 | HIV-1 (drug effects) |
| 3 | Genetic Vectors (genetics) |
| 3 | Evolution, Molecular |
| 3 | Enzyme |
| 3 | Disease Reservoirs (virology) |
| 3 | Detection |
| 3 | Coronavirus Infections (drug therapy) |
| 3 | Coronavirus (metabolism) |
| 3 | Computer Simulation |
| 3 | Communicable Diseases, Emerging |
| 3 | China |
| 3 | Chikungunya virus |
| 3 | Bioterrorism |
| 3 | Binding Sites |
| 3 | Betacoronavirus (genetics) |
| 3 | Asia |
| 3 | Antiviral Agents (chemistry) |
| 3 | Antibodies, Viral (blood) |
| 3 | Acute |
| 3 | AIDS |
| 2 | virtual screening |
| 2 | tagging |
| 2 | surveillance network |
| 2 | proofreading |
| 2 | positive fragmentation |
| 2 | pandemic |
| 2 | outbreak |
| 2 | otolith microchemistry |
| 2 | nursery |
| 2 | molecular epidemiology |
| 2 | models |
| 2 | indicator |
| 2 | grid |
| 2 | epidemiology |
| 2 | diversity |
| 2 | curves |
| 2 | connectivity |
| 2 | biodiversity |
| 2 | artificial habitats |
| 2 | Zoonoses |
| 2 | X-Ray Diffraction |
| 2 | Wild animal |
| 2 | West Nile Fever (epidemiology) |
| 2 | Viruses |
| 2 | Viruses (immunology) |
| 2 | Viruses (genetics) |
| 2 | Virus replication cycle |
| 2 | Virus Replication (drug effects) |
| 2 | Virus Assembly |
| 2 | Virology (methods) |
| 2 | Viral Vaccines (genetics) |
| 2 | Viral Vaccines (administration & dosage) |
| 2 | Viral Nonstructural Proteins (antagonists & inhibitors) |
| 2 | Viral Matrix Proteins (metabolism) |
| 2 | Viral Envelope Proteins (physiology) |
| 2 | Viral Envelope Proteins (biosynthesis) |
| 2 | Viral Envelope Proteins (analysis) |
| 2 | Vaccine |
| 2 | Tropical medicine |
| 2 | Transcription |
| 2 | Time Factors |
| 2 | Thailand |
| 2 | Technology |
| 2 | Stochastic Processes |
| 2 | Standard |
| 2 | Severe Acute Respiratory Syndrome |
| 2 | Severe Acute Respiratory Syndrome (pathology) |
| 2 | Sequence Analysis, DNA |
| 2 | Sequence Alignment |
| 2 | Sentinel Surveillance |
| 2 | Seasons |
| 2 | Sanitary surveillance |
| 2 | SARs |
| 2 | SARS-CoV |
| 2 | SARS epidemic |
| 2 | Risk |
| 2 | Risk Assessment |
| 2 | Respiratory system infection |
| 2 | Respiratory distress |
| 2 | Reservoir |
| 2 | Replication |
| 2 | Recombination, Genetic |
| 2 | Recombinant Proteins (chemistry) |
| 2 | Receptors, Virus (genetics) |
| 2 | Rabbits |
| 2 | RNA, Viral (analysis) |
| 2 | RNA virus |
| 2 | RNA Viruses (genetics) |
| 2 | RNA Helicases (metabolism) |
| 2 | RNA Caps (metabolism) |
| 2 | RNA (metabolism) |
| 2 | Quinolines (pharmacology) |
| 2 | Quinolines (chemistry) |
| 2 | Quinolines (chemical synthesis) |
| 2 | Protein Interaction Maps |
| 2 | Protein Domains |
| 2 | Pregnancy |
| 2 | Pneumopathy |
| 2 | Pneumonia, Viral (virology) |
| 2 | Pneumonia, Viral (prevention & control) |
| 2 | Peptide Fragments (chemistry) |
| 2 | Patient Isolation |
| 2 | Oxidation-Reduction |
| 2 | Nucleocapsid Proteins (immunology) |
| 2 | Nucleocapsid Proteins (genetics) |
| 2 | Non-linear microscopy |
| 2 | Nereis virens |
| 2 | Mutagenesis |
| 2 | Molecular epidemiology |
| 2 | Molecular biology |
| 2 | Molecular Epidemiology |
| 2 | Middle East Respiratory Syndrome Coronavirus |
| 2 | Middle East Respiratory Syndrome Coronavirus (isolation & purification) |
| 2 | Middle East Respiratory Syndrome Coronavirus (immunology) |
| 2 | Microorganism |
| 2 | Methyltransferases (antagonists & inhibitors) |
| 2 | Membrane Glycoproteins (physiology) |
| 2 | Membrane Glycoproteins (genetics) |
| 2 | Membrane Glycoproteins (biosynthesis) |
| 2 | Measles Vaccine (immunology) |
| 2 | Measles Vaccine (genetics) |
| 2 | MERS-CoV |
| 2 | International Cooperation |
| 2 | Influenzavirus |
| 2 | Influenza, Human (diagnosis) |
| 2 | Influenza in Birds (epidemiology) |
| 2 | Influenza A Virus, H5N1 Subtype |
| 2 | Influenza A Virus, H5N1 Subtype (pathogenicity) |
| 2 | Infant, Newborn |
| 2 | Immunity, Innate |
| 2 | Identification |
| 2 | HepG2 cytotoxicity |
| 2 | Health hazards |
| 2 | HEK293 Cells |
| 2 | Genotype |
| 2 | Genetics |
| 2 | Gene Expression Regulation, Viral |
| 2 | France (epidemiology) |
| 2 | Exoribonucleases (chemistry) |
| 2 | Europe (epidemiology) |
| 2 | Enzyme inhibitor |
| 2 | Enteritis |
| 2 | Emergence |
| 2 | Drug Design |
| 2 | Disease Transmission, Infectious (prevention & control) |
| 2 | Discussion |
| 2 | Digital holography |
| 2 | Diagnosis |
| 2 | DNA, Viral (analysis) |
| 2 | Cysteine endopeptidases |
| 2 | Crystallography |
| 2 | Cross Infection (virology) |
| 2 | Cross Infection (transmission) |
| 2 | Cross Infection (epidemiology) |
| 2 | Coronavirus Infections (immunology) |
| 2 | Coronavirus (ultrastructure) |
| 2 | Coronavirus (physiology) |
| 2 | Coronavirus (pathogenicity) |
| 2 | Coronavirus (immunology) |
| 2 | Coronavirus (enzymology) |
| 2 | Coronavirus (drug effects) |
| 2 | Computational Biology |
| 2 | Clinical form |
| 2 | Climate |
| 2 | Chloroquine |
| 2 | Chemical synthesis |
| 2 | Cattle |
| 2 | Catalytic Domain |
| 2 | Cambodia |
| 2 | Brain (virology) |
| 2 | Birds |
| 2 | Bioturbation |
| 2 | Binding mode |
| 2 | Betacoronavirus (classification) |
| 2 | Bacteriosis |
| 2 | Asia (epidemiology) |
| 2 | Antibody Formation |
| 2 | Antibodies, Neutralizing (immunology) |
| 2 | Antibodies, Monoclonal |
| 2 | Anti-HIV Agents (pharmacology) |
| 2 | Anti-HIV Agents (chemical synthesis) |
| 2 | Alphavirus Infections (epidemiology) |
| 2 | Alphacoronavirus (isolation & purification) |
| 2 | Alphacoronavirus (genetics) |
| 2 | Alphacoronavirus (classification) |
| 2 | Algorithms |
| 2 | Aged, 80 and over |
| 2 | 2019-nCoV |
| 2 | SARs |
| 1 | zebrafish |
| 1 | writing aid |
| 1 | wildlife |
| 1 | wild rabbits |
| 1 | virus replication |
| 1 | urea |
| 1 | terminology |
| 1 | term extraction |
| 1 | telemedicine |
| 1 | telehealth |
| 1 | technical writing |
| 1 | taxonomic harmonisation |
| 1 | tRNA Methyltransferases |
| 1 | surveillance |
| 1 | surréalisme |
| 1 | structure-activity relationships |
| 1 | ssRNA viruses |
| 1 | species-area relationship |
| 1 | specialized vocabulary |
| 1 | specialized language |
| 1 | spatial distribution |
| 1 | socioeconomic status |
| 1 | scientific writing |
| 1 | sARS-CoV-2 |
| 1 | rodents |
| 1 | richness |
| 1 | ribavirin |
| 1 | respiratory mortality |
| 1 | regulatory knowledge |
| 1 | regulation |
| 1 | random walk |
| 1 | questionnaires |
| 1 | public health |
| 1 | prediction |
| 1 | pollution |
| 1 | plant diversity |
| 1 | patterns |
| 1 | particulate matter |
| 1 | pareto optimization |
| 1 | one-fifth success rule |
| 1 | one plus one |
| 1 | non-structural protein 14 |
| 1 | nidovirus |
| 1 | modelling |
| 1 | medaka |
| 1 | mapping |
| 1 | m-RT-PCR-ELISA |
| 1 | logistic-regression |
| 1 | linear convergence |
| 1 | language for specific purposes |
| 1 | islands |
| 1 | island biogeography |
| 1 | irradiation |
| 1 | interactive |
| 1 | information systems |
| 1 | influenza |
| 1 | influenza-like illness |
| 1 | industrial chemicals |
| 1 | indexHabitat specialization |
| 1 | immunology |
| 1 | hedgehogs |
| 1 | germline chimeras |
| 1 | genetic diversity |
| 1 | gastrulation |
| 1 | function-value-free optimization |
| 1 | formamide |
| 1 | fold evolution |
| 1 | fish |
| 1 | farmland bird |
| 1 | exoribonuclease |
| 1 | evolution strategy |
| 1 | epidemic modeling |
| 1 | environmental protection agency |
| 1 | environment |
| 1 | endoderm |
| 1 | emergency preparedness |
| 1 | embryo |
| 1 | diversity-area relationship |
| 1 | distributions |
| 1 | dispersal |
| 1 | disease outbreaks |
| 1 | disasters |
| 1 | disaster planning |
| 1 | digital medicine |
| 1 | digital health |
| 1 | derivative-free optimization |
| 1 | data collection |
| 1 | correspondance |
| 1 | coronaviruses |
| 1 | controlled language |
| 1 | containment |
| 1 | contact tracing |
| 1 | comparison-based |
| 1 | climate-change |
| 1 | cell transplantation |
| 1 | cell migration |
| 1 | casanova |
| 1 | bats |
| 1 | bHLH |
| 1 | avian flu |
| 1 | avant-gardes |
| 1 | antiviral agents |
| 1 | antiplasmodial activity |
| 1 | agricultural intensity |
| 1 | agri-environment schemes |
| 1 | agri-environment scheme |
| 1 | accumulation |
| 1 | Zoonoses (transmission) |
| 1 | Zoonoses (prevention & control) |
| 1 | Zoonoses (etiology) |
| 1 | Zimbabwe |
| 1 | Zika Virus Infection |
| 1 | Zika Virus Infection (transmission) |
| 1 | Zika Virus Infection (prevention & control) |
| 1 | Zika Virus Infection (epidemiology) |
| 1 | Zika Virus Infection (diagnosis) |
| 1 | ZOOPLANKTON |
| 1 | X-Ray |
| 1 | X-BAND |
| 1 | West Nile Fever (transmission) |
